Literature DB >> 8750616

Plasma creatine kinase and cardiomyopathy in glycogen storage disease type III.

P Lee1, M Burch, J V Leonard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8750616     DOI： 10.1007/bf02436768

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  5 in total

1.  Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy.

Authors:  R A Coleman; H S Winter; B Wolf; J M Gilchrist; Y T Chen
Journal:  Ann Intern Med       Date:  1992-06-01       Impact factor: 25.391

2.  Cardiac involvement in glycogen storage disease type III.

Authors:  S W Moses; K L Wanderman; A Myroz; M Frydman
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

3.  Cardiologic abnormalities in Noonan syndrome: phenotypic diagnosis and echocardiographic assessment of 118 patients.

Authors:  M Burch; M Sharland; E Shinebourne; G Smith; M Patton; W McKenna
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

4.  Cardiomyopathy in glycogen-storage disease type III: clinical and echographic study of 18 patients.

Authors:  P Labrune; P Huguet; M Odievre
Journal:  Pediatr Cardiol       Date:  1991-07       Impact factor: 1.655

Review 5.  The hepatic glycogen storage diseases--problems beyond childhood.

Authors:  P J Lee; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982
  5 in total
  6 in total

1.  Cardiac Pathology in Glycogen Storage Disease Type III.

Authors:  S L Austin; A D Proia; M J Spencer-Manzon; J Butany; S B Wechsler; P S Kishnani
Journal:  JIMD Rep       Date:  2012-01-31

Review 2.  Metabolic cardiomyopathies.

Authors:  B Guertl; C Noehammer; G Hoefler
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 3.  Glycogen storage diseases: new perspectives.

Authors:  Hasan Ozen
Journal:  World J Gastroenterol       Date:  2007-05-14       Impact factor: 5.742

4.  Molecular and biochemical characterization of a novel intronic single point mutation in a Tunisian family with glycogen storage disease type III.

Authors:  Faten Ben Rhouma; Hatem Azzouz; François M Petit; Mariem Ben Khelifa; Amel Ben Chehida; Fehmi Nasrallah; Frédéric Parisot; Khaled Lasram; Rym Kefi; Yosra Bouyacoub; Lilia Romdhane; Christiane Baussan; Naziha Kaabachi; Marie-Françoise Ben Dridi; Neji Tebib; Sonia Abdelhak
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

5.  Echocardiographic manifestations of Glycogen Storage Disease III: increase in wall thickness and left ventricular mass over time.

Authors:  Shawyntee M Vertilus; Stephanie L Austin; Kimberly S Foster; Keri E Boyette; Deeksha S Bali; Jennifer S Li; Priya S Kishnani; Stephanie Burns Wechsler
Journal:  Genet Med       Date:  2010-07       Impact factor: 8.822

6.  Characterization of a canine model of glycogen storage disease type IIIa.

Authors:  Haiqing Yi; Beth L Thurberg; Sarah Curtis; Stephanie Austin; John Fyfe; Dwight D Koeberl; Priya S Kishnani; Baodong Sun
Journal:  Dis Model Mech       Date:  2012-06-26       Impact factor: 5.758
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.